JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266266

Human TACC1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TACC1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 3 and 8 bp deletion in exon 3.

View Alternative Names

DKFZp686K18126, Ga 55, Gastric cancer antigen Ga 55, KIAA1103, TACC1_HUMAN, Taxin-1, Transforming acidic coiled-coil-containing protein 1

2 Images
Sanger Sequencing - Human TACC1 knockout HEK-293T cell line (AB266266)
  • Sanger seq

Unknown

Sanger Sequencing - Human TACC1 knockout HEK-293T cell line (AB266266)

Allele-1 : 19 bp deletion in exon3

Sanger Sequencing - Human TACC1 knockout HEK-293T cell line (AB266266)
  • Sanger seq

Unknown

Sanger Sequencing - Human TACC1 knockout HEK-293T cell line (AB266266)

Allele-2 : 8 bp deletion in exon 3.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 19 bp deletion in exon 3 and 8 bp deletion in exon 3

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266266-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266266 Human TACC1 knockout HEK-293T cell line", "number":"AB266266-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266266-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266266 Human TACC1 knockout HEK-293T cell line", "number":"AB266266-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TACC1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TACC1 also known as Transforming Acidic Coiled-Coil-Containing Protein 1 is a significant protein with a molecular mass of approximately 80 kDa. This protein primarily interacts in the centrosome and spindle microtubules of cells. TACC1 is an important player in regulating microtubule dynamics during mitosis and is widely expressed in various tissues including the brain liver and testis. The protein structure contains coiled-coil domains important for its function in stabilization and organization of microtubules.
Biological function summary

TACC1 engages in processes that contribute to proper cell division and genomic stability. It forms part of a larger molecular complex that includes components like the ch-TOG partner assisting in anchoring and stabilizing microtubules important for mitotic spindle function. TACC1 indirectly affects the balance between cell proliferation and apoptosis showing its importance in maintaining healthy cell cycles. Its role in spindle formation ensures accurate segregation of chromosomes which is critical for preventing aneuploidies.

Pathways

TACC1 is involved in mitotic signaling and microtubule organization pathways. It interacts with Aurora A kinase an essential element of the mitotic entry pathway ensuring that kinetochores are properly attached to spindle microtubules during mitosis. Another pathway involves the PI3K/AKT signaling where TACC1 may influence cellular responses to growth factors. Its interaction with Aurora A demonstrates the protein's importance in centrosome maturation and spindle stability highlighting its role in cell cycle regulation.

TACC1 relates to certain cancers particularly breast and ovarian cancer. Aberrant expression or mutations of TACC1 can lead to disrupted cellular proliferation control and genomic instability. In breast cancer TACC1 often shows altered expression alongside BRCA1 suggesting a direct connection within pathways that govern tumor suppression and DNA repair. Ovarian cancer studies also indicate that changes in TACC1 levels could correlate with tumor aggressiveness positioning it as a potential prognostic marker.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com